amifostine anhydrous has been researched along with MS (Multiple Sclerosis) in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Wu, DM | 1 |
| Yu, Y | 1 |
| Deng, SH | 1 |
| Liu, T | 1 |
| Zhang, T | 1 |
| He, M | 1 |
| Zhao, YY | 1 |
| Xu, Y | 1 |
1 other study available for amifostine anhydrous and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: Effect on reactive oxygen species/NLRP3 pathway.
Topics: Amifostine; Animals; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Mice; | 2020 |